CMPO
MergedCMPO — Post-Mortem
CompoSecure, Inc., a technology firm specializing in engineered payment solutions, made headlines with its ambitious plan to acquire Husky Technologies for approximately $3.953 billion, which was set to be finalized on December 23, 2025. This transaction aimed to enhance CompoSecure's position in the market through substantial capital infusion. However, on that date, the company failed to secure the required shareholder approval for its Stock Issuance Proposal. This vote was pivotal, as it would determine the fate of significant share allocations linked to the acquisition. Despite efforts from the Board, which deemed the transaction fair and in the best interests of stakeholders, the absence of necessary support culminated in CompoSecure's delisting from the NYSE. The abrupt end of this un
CompoSecure, Inc. (CMPO) faced delisting following a failed shareholder vote on a major acquisition.
Could I Have Seen This Coming?
No structured pre-delisting signals found in our records. Absence of signals does not imply absence of risk.
Post-Mortem Analysis
Five-section narrative grounded in primary filings and contemporaneous reporting.
Origin
The company originated as a technology provider specializing in premium payment solutions.
Peak
The peak of the company's valuation came with the announcement of the Husky acquisition in November 2025, valuing the deal at approximately $3.953 billion.
Turning Point
The critical turning point occurred on December 23, 2025, when shareholders voted against the Stock Issuance Proposal necessary for the deal to move forward.
End
Ultimately, CompoSecure faced delisting from the NYSE due to the failed acquisition attempt, signaling a failure to maintain compliance with exchange listing requirements.
Impact
The failed acquisition and subsequent delisting were significant setbacks, impacting shareholder confidence and the company's ability to attract future investments.
Lessons for Today's Investors
Transferable patterns identified from this case, written as research-report observations.
- 1
The importance of shareholder engagement cannot be overstated; adequate communication and support mechanisms must be in place to secure necessary votes during critical transactions.
- 2
Strategic acquisitions require thorough due diligence and consensus among stakeholders to materialize successfully.
- 3
Companies must be prepared for the implications of failed shareholder votes, as these can have lasting impacts on stock performance and market standing.
Frequently Asked Questions
What was the primary reason for CompoSecure's delisting?
What was the financial scale of the proposed acquisition?
What does the delisting mean for current shareholders?
Source Filings
Every fact on this page is anchored to a primary SEC filing or regulatory record. Open any source to verify against the original document.
SEC EDGAR · Form DEFM14AFiled Nov 24, 2025
CompoSecure agreed to issue and sell approximately 106,057,000 shares of its Common Stock at a purchase price of $18.50 per share in a private placement, totaling approximately $1.96 billion.
SEC EDGAR · Form DEFM14AFiled Nov 24, 2025
The special meeting of CompoSecure stockholders to vote on the Stock Issuance Proposal was scheduled for December 23, 2025, at 10:00 a.m. Eastern Time.
SEC EDGAR · Form DEFM14AFiled Nov 24, 2025
As of the record date, November 20, 2025, there were 126,411,164 shares of CompoSecure Common Stock outstanding.
SEC EDGAR · Form DEFM14AFiled Nov 24, 2025
The Board of Directors of CompoSecure determined that the Transaction Agreement and the Transactions are fair and in the best interests of CompoSecure and its stockholders.
SEC EDGAR · Form DEFM14AFiled Nov 24, 2025
Husky will become an indirect wholly owned subsidiary of CompoSecure following the closing of the transactions contemplated by the Transaction Agreement.
SEC EDGAR · Form DEFM14AFiled Nov 24, 2025
The Stock Issuance Proposal requires the affirmative vote of the holders of a majority of votes cast at the special meeting, assuming a quorum is present.
SEC EDGAR · Form DEFM14AFiled Nov 24, 2025
At the special meeting, stockholders will be asked to approve the issuance of CompoSecure Common Stock pursuant to the terms of the Transaction Agreement and the Purchase Agreements.
SEC EDGAR · Form 25Filed Sep 22, 2025
Removed from listing - SEC Form 25 filed.
Narrative sections on this page are AI-assisted summaries of the filings linked above. All content is reviewed against primary sources; if you find an error, the canonical record is always the linked filing.